Experimental Transcatheter Device Yields Consistent, Positive Outcomes for Patients
from Cardiovascular Business
An experimental transcatheter device by Canada-based Neovasc, used to treat mitral regurgitation, was shown to be effective in treating a patient with several severe heart conditions. The Tiara, still an investigational device, was shown in a presentation by Shmuel Banai, M.D., the director of interventional cardiology at the Tel Aviv Medical Center and Neovasc’s medical director, at this year’s Transcatheter Valve Therapies conference.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063